Interferon α therapy in patients with chronic hepatitis C infection: Quality of life and depression

Hematology Reports

Volumn 7, Issue 1, 2015, Pages 5-8

  Conversano, Ciro ^a   Carmassi, Claudia ^a   Carlini, Marina ^a   Casu, Giulia ^b   Gremigni, Paola ^b   Dell’Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Depression; HCV; Interferon; Quality of life

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPRESSION ASSESSMENT; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MENTAL HEALTH; PAIN; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION;

EID: 84924131733     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2015.5632     Document Type: Article

References (19)

1. Pockros PJ. Developments in the treatment of chronic hepatitis C. Expert Opin Investig Drugs 2002; 11: 515-28.
2. Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
3. Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, et al. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol 2005; 39: 731-6.
4. Spiegel BM, Younossi ZM, Hays RD, et al. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005; 41: 790-800.
5. Taliani G, Rucci P, Biliotti E, et al. Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. J Vir Hep 2007; 14: 875-82.
6. Shepherd J, Brodin HF, Cave CB, et al. Clinical-and cost-effectiveness of pegylat-ed interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Int J Tech Assess Health Care 2005; 21: 47-54.
7. Quelhas R, Lopes A. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review. J Psychiatr Pract 2009; 15: 262-81.
8. Horsmans Y. Interferon-induced depression in chronic hepatitis C. J Antimicrob Chemother 2006; 58: 711-3.
9. Keefe B. Interferon-induced depression in hepatitis C: an update. Curr Psychiatry Rep 2007; 9: 255-61.
10. Kang SC, Hwang SJ, Lee SH, et al. Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005; 11: 7494-8.
11. Chang SC, Ko WS, Wu SS, et al. Factors associated with quality of life in chronic hepatitis C patients who received interferon plus ribavirin therapy. J Formos Med Assoc 2008; 107: 454-62.
12. Małyszczak K, Inglot M, Pawłowski T, et al. Depressive symptoms during treatment with interferon alpha for HCV infection-preliminary report. Psychiatr Pol 2006; 40: 799-808.
13. Baranyi A, Meinitzer A, Stepan A, et al. [Interferon therapy in patients with chronic hepatitis C infection: Biopsychosocial consequences]. Nervenarzt 2011; 83: 1169-77. [Article in German].
14. Pojoga C, Dumitra cu DL, Pascu O, Grigorescu M. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience. J Gastrointestin Liver Dis 2006; 15: 31-5.
15. Hunt CM, Dominitz JA, Bute BP, et al. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 1997; 42: 2482-6.
16. Dell’Osso L, Pini S, Maggi L, et al. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders. J Psychosom Res 2007; 62: 349-55.
17. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-IV-patient edition (SCID-P). Washington, DC: American Psychiatric Press; 1995.
18. Apolone G, Mosconi P, Ware JE Jr. Questionario sullo stato di salute SF-36. Milan: Guerini e Associati Spa; 1997.
19. Hollander A, Foster GR, Weiland O. Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C. Scand J Gastroenterol 2006; 41: 577-85.